513 related articles for article (PubMed ID: 11336935)
1. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
Inomata H; Rao NA
Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
[TBL] [Abstract][Full Text] [Related]
2. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
Lee EK; Lee SY; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green angiographic findings of Dalen-Fuchs nodules in Vogt-Koyanagi-Harada disease.
Wu W; Wen F; Huang S; Luo G; Wu D
Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):937-40. PubMed ID: 17219113
[TBL] [Abstract][Full Text] [Related]
4. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
[TBL] [Abstract][Full Text] [Related]
5. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.
Vasconcelos-Santos DV; Sohn EH; Sadda S; Rao NA
Retina; 2010 Jan; 30(1):33-41. PubMed ID: 20010321
[TBL] [Abstract][Full Text] [Related]
6. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
7. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
Abu El-Asrar AM; Al Mudhaiyan T; Al Najashi AA; Hemachandran S; Hariz R; Mousa A; Al-Muammar A
Ocul Immunol Inflamm; 2017 Aug; 25(4):475-485. PubMed ID: 27003480
[TBL] [Abstract][Full Text] [Related]
8. Pathology of Vogt-Koyanagi-Harada disease.
Rao NA
Int Ophthalmol; 2007; 27(2-3):81-5. PubMed ID: 17435969
[TBL] [Abstract][Full Text] [Related]
9. Melanin change of retinal pigment epithelium and choroid in the convalescent stage of Vogt-Koyanagi-Harada disease.
Huang Y; Yang YT; Lin B; Huang SH; Sun ZH; Zhou R; Li YZ; Liu XL
Int J Ophthalmol; 2020; 13(12):1928-1932. PubMed ID: 33344192
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease.
Suzuki S
Jpn J Ophthalmol; 1999; 43(4):327-33. PubMed ID: 10482481
[TBL] [Abstract][Full Text] [Related]
13. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
Keino H; Goto H; Usui M
Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
[TBL] [Abstract][Full Text] [Related]
14. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
15. Vogt-Koyanagi-Harada syndrome variant.
Dewan S; Chisholm IA
Can J Ophthalmol; 1989 Apr; 24(3):109-11. PubMed ID: 2731070
[TBL] [Abstract][Full Text] [Related]
16. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
17. Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease.
Guo YL; Du Y; He JF
Am J Ophthalmol; 2009 May; 147(5):946; author reply 946-7. PubMed ID: 19376333
[No Abstract] [Full Text] [Related]
18. Therapeutic window of opportunity in the acute uveitic phase of Vogt-Koyanagi-Harada disease: Prevention of late autoimmune complications by early intervention.
Abu El-Asrar AM; Al Rashed FA; AlBloushi AF; Tobaigy MF; Gikandi PW; Herbort CP; Opdenakker G
Acta Ophthalmol; 2023 Mar; 101(2):e236-e245. PubMed ID: 36128841
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival nodules associated with Vogt-Koyanagi-Harada disease.
Nakao K; Shimonagano Y; Doi N; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1383-6. PubMed ID: 17701198
[TBL] [Abstract][Full Text] [Related]
20. Polarization-Sensitive Optical Coherence Tomographic Documentation of Choroidal Melanin Loss in Chronic Vogt-Koyanagi-Harada Disease.
Miura M; Makita S; Yasuno Y; Tsukahara R; Usui Y; Rao NA; Ikuno Y; Uematsu S; Agawa T; Iwasaki T; Goto H
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4467-4476. PubMed ID: 28863408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
